Triple
T33637310
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | RE-LY trial |
E861731
|
entity |
| Predicate | keyFinding |
P42880
|
FINISHED |
| Object | dabigatran 150 mg twice daily increased gastrointestinal bleeding compared with warfarin |
—
|
LITERAL FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: dabigatran 150 mg twice daily increased gastrointestinal bleeding compared with warfarin | Statement: [RE-LY trial, keyFinding, dabigatran 150 mg twice daily increased gastrointestinal bleeding compared with warfarin]
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f3498280c48190bcc3494017d14234 |
completed | April 30, 2026, 12:22 p.m. |
| NER | Named-entity recognition | batch_69f6f973ad6c8190a6ec9ac22e9eb9df |
completed | May 3, 2026, 7:29 a.m. |
Created at: May 1, 2026, 1:42 a.m.